Cherry Biolabs Gmbh competitive analysis

Explore patent oppositions filed by Cherry Biolabs Gmbh against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Functional Antibody Fragment Complementation For A Two-Components System For Redirected Killing Of Unwanted CellsREVITOPE LIMITEDDec 16, 2021

Latest PTAB cases involving Cherry Biolabs Gmbh

Discover the latest PTAB cases involving Cherry Biolabs Gmbh, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Cherry Biolabs Gmbh with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CHERRY BIOLABS GMBH1 - - -
REVITOPE LIMITED12 - -